Summary
Multiple sclerosis is an inflammatory demyelinating disease of the central nervous system. The etiology is unknown, but several lines of evidence support the hypothesis that the pathogenesis is mediated by autoreactive T lymphocytes. Molecular mimicry has been proposed as a possible mechanism for the development of an autoimmune response to myelin antigens. According to this model, an immune reaction to self antigens could be initiated by T cells that cross-react with infectious agents that “mimic” the autoantigen, i.e. they share immunologic epitopes. It was previously thought that, in order for a cross-reaction of T cells to two different antigens to occur, a substantial amino acid sequence homology between the two antigens was required. More recent studies on the basic mechanisms of T cell antigen recognition have shown that, at least for some T cell clones, antigen recognition is more “degenerate” and sequence homology is not required for crossreactivity to occur. This article reviews the relevance of these recent advances in basic T cell receptor immunology to the occurrence of autoimmunity in the central nervous system.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Alberola-Ila J, Takaki S, Kerner JD, Perlmutter RM (1997) Differential signaling by lymphocyte antigen receptors. Annu Rev Immunol 15: 125–154.
Barnaba V, Sinigaglia F (1997) Molecular mimicry and T cell-mediated autoimmune disease. J Exp Med 185: 1529–1531.
Cannella B, Cross AH, Raine CS (1990) Upregulation and coexpression of adhesion molecules correlate with relapsing autoimmune demyelination in the central nervous system. J Exp Med 172: 1521–1524.
Davies JM (1997) Molecular mimicry: can epitope mimicry induce autoimmune disease? Immunol Cell Biol 75: 113–126.
Ebers GC, Sadovnick AD, Risch NJ (1995) A genetic basis for familial aggregation in multiple sclerosis. Canadian Collaborative Study Group. Nature 377: 150–151.
Ebers GC, Kukay K, Bulman DE, Sadovnick AD, Rice G, Anderson C, Armstrong H, Cousin K, Bell RB, Hader W, Paty DW, Hashimoto S, Oger J, Duquette P, Warren S, Gray T, O’Connor P, Nath A, Auty A, Metz L, Francis G, Paulseth JE, Murray TJ, Pryse-Phillips W, Risch N, et al (1996) A full genome search in multiple sclerosis. Nat Genet 13: 472–476.
Evavold BD, Sloan-Lancaster J, Allen PM (1993) Tickling the TCR: selective T-cell functions stimulated by altered peptide ligands. Immunol Today 14: 602–609.
Evavold BD, Sloan-Lancaster J, Wilson KJ, Rothbard JB, Allen PM (1995) Specific T cell recognition of minimally homologous peptides: evidence for endogenous ligands. Immunity 2: 655–663.
Fritz RB, Skeen MJ, Jen-Chou CH, Garcia M, Egorov IK (1985) Major histocompatibility complex-linked control of the murine immune response to myelin basic protein. J Immunol 134: 2328–2332.
Fujinami RS, Oldstone MBA (1985) Amino acid homology between the encephalitogenic site of myelin basic protein and virus: mechanism for autoimmunity. Science 230: 1043–1045.
Germain RN (1994) MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell 76: 287–299.
Germain RN, Margulies DH (1993) The biochemistry and cell biology of antigen processing and presentation. Annu Rev Immunol 11: 403–450.
Goverman J, Woods A, Larson L, Weiner L, Hood L, Zaller DM (1993) Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity. Cell 72: 551–560.
Haines JL, Ter-Minassian M, Bazyk A, Gusella JF, Kim DJ, Terwedow H, Pericak-Vance MA, Rimmler JB, Haynes CS, Roses AD, Lee A, Shaner B, Menold M, Seboun E, Fitoussi RP, Gartioux C, Reyes C, Ribierre F, Gyapay G, Weissenbach J, Hauser SL, Goodkin DE, Lincoln R, Usuku K, Oksenberg JR et al (1996) A complete genomic screen for multiple sclerosis underscores a role for the major histocompatability complex. Nat Genet 13: 469–471.
Hao Q, Saida T, Kawakami H, Mine H, Maruya E, Inoko H, Saji H (1992) HLAs and genes in Japanese patients with multiple sclerosis: evidence for increased frequencies of HLA-Cw3, HLA-DR2, and HLA-DQBl*0602. Hum Immunol 35: 116–124.
Hemmer B, Fleckenstein BT, Vergelli M, Jung G, McFarland H, Martin R, Wiesmueller KH (1997) Identification of high potency microbial and self ligands for a human autoreactive class II-restricted T cell clone. J Exp Med 185: 1651–1659.
Hemmer B, Vergelli M, Gran B, Ling N, Conlon P, Pinilla C, Houghten R, McFarland HF, Martin R (1998a) Cutting edge: predictable TCR antigen recognition based on peptide scans leads to the identification of agonist ligands with no sequence homology. J Immunol 160: 3631–3636.
Hemmer B, Vergelli M, Pinilla C, Houghten R, Martin R (1998b) Probing degeneracy in T-cell recognition using peptide combinatorial libraries. Immunol Today 19: 163–168.
Houghten RA, Pinilla C, Blondelle SE, Appel JR, Dooley CT, Cuervo JH (1991) Generation and use of synthetic peptide combinatorial libraries for basic research and drug discovery. Nature 354: 84–86.
Kuokkanen S, Sundvall M, Terwilliger JD, Tienari PJ, Wikstrom J, Holmdahl R, Pettersson U, Peltonen L (1996) A putative vulnerability locus to multiple sclerosis maps to 5pl4-pl2 in a region syntenic to the murine locus Eae2. Nat Genet 13: 477–480.
Kurtzke J (1985) Epidemiology of multiple sclerosis. In: Vinken PJ, Bruyn GB, Klawans HL, et al (eds) Handbook of clinical neurology, vol 3: Demyelinating diseases. Elsevier, Amsterdam, pp 259–287.
Kurtzke JF (1993) Epidemiologic evidence for multiple sclerosis as an infection. Clin Microbiol Rev 6: 382–427.
Marrosu MG, Muntoni F, Murru MR, Spinicci G, Pischelda MP, Goddi F, Cossu P, Pirastu M (1988) Sardinian multiple sclerosis is associated with HLA-DR4: a serological and molecular analysis. Neurology 38: 1749–1753.
Martin R, McFarland HF (1997) Immunology of multiple sclerosis and experimental allergic encephalomyelitis. In: Raine CS, McFarland HF, Tourtellotte WW (eds) Multiple sclerosis: clinical and pathogenetic basis. Chapman Hall, London, pp 221–242.
Martin R, McFarland HF, McFarlin DE (1992) Immunological aspects of demyelinating diseases. Annu Rev Immunol 10: 153–187.
Nossal GJ (1994) Negative selection of lymphocytes. Cell 76: 229–239.
Oldstone MB (1987) Molecular mimicry and autoimmune disease. Cell 50: 819–820.
Pinilla C, Appel JR, Houghten RA (1994) Investigation of antigen-antibody interactions using a soluble, non-support-bound synthetic decapeptide library composed of four trillion (4 X 10(12)) sequences. Biochem J 301: 847–853.
Raine CS (1997) The lesion in multiple sclerosis and chronic relapsing experimental allergic encephalomyelitis: a structural comparison. In: Raine CS, McFarland HF, Tourtellotte WW (eds) Multiple sclerosis: clinical and pathogenetic basis. Chapman Hall, London, pp 243–286.
Rammensee HG, Friede T, Stevanovic S (1995) MHC ligands and peptide motifs: first listing. Immunogenetics 41: 178–228.
Remlinger J (1905) Accidents paralytiques au cours du traitment antirabique. Ann Inst Pasteur 19: 625–646.
Rivers TM, Sprunt DH, Berry GP (1993) Observations on attempts to produce acute disseminated encephalomyelitis in monkeys. J Exp Med 58: 39–53.
Sawcer S, Jones HB, Feakes R, Gray J, Smaldon N, Chataway J, Robertson N, Clayton D, Goodfellow PN, Compston A (1996) A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22. Nat Genet 13: 464–468.
Schlüsener H, Wekerle H (1985) Autoaggressive T lymphocyte lines recognize the encephalitogenic region of myelin basic protein; in vitro selection from unprimed rat T lymphocyte populations. J Immunol 135: 3128–3133.
Vartdal F, Sollid LM, Vandvik B, Markussen G, Thorsby E (1989) Patients with multiple sclerosis carry DQB1 genes which encode shared polymorphic aminoacid sequences. Hum Immunol 25: 103–110.
Vergelli M, Hemmer B, Utz U, Vogt A, Kalbus M, Tranquill L, Conlon P, Ling N, Steinman L, McFarland HF, Martin R (1996) Differential T cell activation by altered peptide ligands derived from myelin basic protein peptide (87–99). Eur J Immunol 26: 2624–2634.
Vergelli M, Hemmer B, Kalbus M, Vogt A, Ling N, Conlon P, Coligan JE, McFarland HF, Martin R (1997) Modifications of peptide ligands enhancing T cell responsiveness imply large numbers of stimulatory ligands for autoreactive T cells. J Immunol 158: 3746–3752.
Vogt AB, Kropshofer H, Kaibacher H, Kalbus M, Rammensee HG, Coligan JE, Martin R (1994) Ligand motifs of HLA-DRB5*0101 and DRB1*1501 molecules delineated from self-peptides. J Immunol 153: 1665–1673.
von Boehmer H (1994) Positive selection of lymphocytes. Cell 76: 219–228.
Wucherpfennig KW, Strominger JL (1995) Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell 80: 695–705.
Wucherpfennig KW, Sette A, Southwood S, Oseroff C, Matsui M, Strominger JL, Hafler DA (1994) Structural requirements for binding of an immunodominant myelin basic protein peptide to DR2 isotypes and for its recognition by human T cell clones. J Exp Med 179: 279–290.
Yednock TA, Cannon C, Fritz LC, Sanchez-Madrid F, Steinman L, Karin N (1992) Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin. Nature 356: 63–66.
Zinkernagel RM, Doherty PC (1974) Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system. Nature 248: 701–702.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer-Verlag/Wien
About this paper
Cite this paper
Gran, B., Hemmer, B., Martin, R. (1999). Molecular mimicry and multiple sclerosis — a possible role for degenerate T cell recognition in the induction of autoimmune responses. In: Poewe, W., Ransmayr, G. (eds) Advances in Research on Neurodegeneration. 6th International Winter Conference on N eurodegeneration, vol 55. Springer, Vienna. https://doi.org/10.1007/978-3-7091-6369-6_3
Download citation
DOI: https://doi.org/10.1007/978-3-7091-6369-6_3
Publisher Name: Springer, Vienna
Print ISBN: 978-3-211-83261-5
Online ISBN: 978-3-7091-6369-6
eBook Packages: Springer Book Archive